GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abliva AB (OSTO:ABLI) » Definitions » Shiller PE Ratio

Abliva AB (OSTO:ABLI) Shiller PE Ratio : (As of Jun. 11, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Abliva AB Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Abliva AB Shiller PE Ratio Historical Data

The historical data trend for Abliva AB's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abliva AB Shiller PE Ratio Chart

Abliva AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Abliva AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Abliva AB's Shiller PE Ratio

For the Biotechnology subindustry, Abliva AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abliva AB's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abliva AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Abliva AB's Shiller PE Ratio falls into.



Abliva AB Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Abliva AB's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Abliva AB's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.02/132.2054*132.2054
=-0.020

Current CPI (Mar. 2024) = 132.2054.

Abliva AB Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.545 100.432 -0.717
201409 -0.142 100.161 -0.187
201412 -0.363 100.225 -0.479
201503 -0.395 99.950 -0.522
201506 -0.427 99.995 -0.565
201509 -1.382 100.228 -1.823
201512 -0.182 100.276 -0.240
201603 -0.276 100.751 -0.362
201606 -0.269 101.019 -0.352
201609 -0.679 101.138 -0.888
201612 -0.197 102.022 -0.255
201703 -0.316 102.022 -0.409
201706 -0.397 102.752 -0.511
201709 -0.230 103.279 -0.294
201712 -0.256 103.793 -0.326
201803 -0.244 103.962 -0.310
201806 -0.390 104.875 -0.492
201809 -0.195 105.679 -0.244
201812 -0.146 105.912 -0.182
201903 -0.117 105.886 -0.146
201906 -0.137 106.742 -0.170
201909 -0.078 107.214 -0.096
201912 -0.146 107.766 -0.179
202003 -0.098 106.563 -0.122
202006 -0.137 107.498 -0.168
202009 -0.029 107.635 -0.036
202012 -0.039 108.296 -0.048
202103 -0.068 108.360 -0.083
202106 -0.080 108.928 -0.097
202109 -0.090 110.338 -0.108
202112 -0.090 112.486 -0.106
202203 -0.050 114.825 -0.058
202206 -0.040 118.384 -0.045
202209 -0.040 122.296 -0.043
202212 -0.010 126.365 -0.010
202303 -0.020 127.042 -0.021
202306 -0.020 129.407 -0.020
202309 -0.030 130.224 -0.030
202312 -0.020 131.912 -0.020
202403 -0.020 132.205 -0.020

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Abliva AB  (OSTO:ABLI) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Abliva AB Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Abliva AB's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Abliva AB (OSTO:ABLI) Business Description

Traded in Other Exchanges
Address
Scheeletorget 1, Medicon Village, Lund, SWE, 223 81
Abliva AB is a Swedish company that is active in pharmaceutical development. It develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare, and often very severe diseases occur when the cell's energy provider, the mitochondria, does not function properly. The portfolio includes projects at different stages and ranges from the early discovery phase to the clinical phase.

Abliva AB (OSTO:ABLI) Headlines

No Headlines